{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:42:28Z","timestamp":1792006948776,"version":"4.4.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sanofi and Roche Diagnostics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,9]]},"DOI":"10.1093\/eurjpc\/zwae110","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T12:53:55Z","timestamp":1710852835000},"page":"e75-e78","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0046-0264","authenticated-orcid":false,"given":"Michael","family":"Szarek","sequence":"first","affiliation":[{"name":"Division of Cardiology, University of Colorado School of Medicine , Box B130, Aurora, CO 80045 , USA"},{"name":"CPC Clinical Research , 2115 N. Scranton Street, Suite 2040, Aurora, CO 80045 , USA"},{"name":"Department of Epidemiology and Biostatistics, State University of New York, Downstate Health Sciences University School of Public Health , 450 Clarkson Avenue, Brooklyn, NY 11203 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Reijnders","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Centre , LUMC Main Building, Albinusdreef 2, 2333 ZA Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph Gabriel","family":"Steg","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Cit\u00e9 , 85 boulevard Saint-Germain, 75006 Paris , France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Bichat, FACT (French Alliance for Cardiovascular Trials) , INSERM U1148, 46 rue Henri Huchard, 75018 Paris , France"},{"name":"Institut Universitaire de France , 1 rue Descartes, 75005 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Wouter","family":"Jukema","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center , PO Box 9600, 2300 RC Leiden , The Netherlands"},{"name":"Netherlands Heart Institute , Moreelsepark 1, 3511 EP Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schwertfeger","sequence":"additional","affiliation":[{"name":"RCardiometabolism, Neuroscience, Endocrinology, PHCS, PoC, RDS Clinical Development and Medical Affairs (CDMA) , Roche Diagnostics International Ltd., Building 5\/Floor 10, Forrenstrasse 2, 6343 Rotkreuz , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System , 1 Gustave Levy Place, Box 1030, New York, NY 10029 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera A","family":"Bittner","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Disease, University of Alabama at Birmingham , 701 19th Street South - LHRB 310, Birmingham, AL 35294 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2181-9579","authenticated-orcid":false,"given":"Rafael","family":"Diaz","sequence":"additional","affiliation":[{"name":"Estudios Cardiol\u00f3gicos Latino Am\u00e9rica, Instituto Cardiovascular de Rosario , Paraguay 160, Rosario, Santa Fe, Rosario 2000, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Fazio","sequence":"additional","affiliation":[{"name":"Scientific Council \u2013Cardiometabolic Global Development, Regeneron Pharmaceuticals Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Garon","sequence":"additional","affiliation":[{"name":"Global Medical Department - General Medicines GBU, Sanofi , Ontario M2R 3T4 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-2440","authenticated-orcid":false,"given":"Shaun G","family":"Goodman","sequence":"additional","affiliation":[{"name":"Canadian VIGOUR Centre, University of Alberta , 87 Ave NW, Edmonton, Alberta T6G 2E1 , Canada"},{"name":"Division of Cardiology, St. Michael\u2019s Hospital, Room 6-034 Donnelly Wing , Toronto, Ontario M5B 1W8 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Harrington","sequence":"additional","affiliation":[{"name":"Stephen and Suzanne Weiss Dean, Weill Cornell Medicine , 1300 York Avenue, F-113, New York, NY 10065 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-6750","authenticated-orcid":false,"given":"Harvey D","family":"White","sequence":"additional","affiliation":[{"name":"Green Lane Cardiovascular Services , Auckland City Hospital, 5 Park Road, Grafton, Auckland 1142 , New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M","family":"Zeiher","sequence":"additional","affiliation":[{"name":"Department of Medicine III, Goethe University , Theodor-Stern-Kai 7, Frankfurt am Main 60590 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Cobbaert","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Centre , LUMC Main Building, Albinusdreef 2, 2333 ZA Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory G","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Colorado School of Medicine , Box B130, Aurora, CO 80045 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"2024080903361746800_zwae110-B1","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein(a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"key":"2024080903361746800_zwae110-B2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamacardio.2018.1470","article-title":"Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: a Mendelian randomization analysis","volume":"3","author":"Burgess","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2024080903361746800_zwae110-B3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamacardio.2019.1041","article-title":"Estimation of the required lipoprotein(a)-lowering therapeutic effect size for reduction in coronary heart disease outcomes: a Mendelian randomization analysis","volume":"4","author":"Lamina","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2024080903361746800_zwae110-B4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2019.10.057","article-title":"Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome","volume":"75","author":"Bittner","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024080903361746800_zwae110-B5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O\u2019Donoghue","year":"2019","journal-title":"Circulation"},{"key":"2024080903361746800_zwae110-B6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(18)31652-0","article-title":"Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials","volume":"392","author":"Willeit","year":"2018","journal-title":"Lancet"},{"key":"2024080903361746800_zwae110-B7","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1093\/eurheartj\/ehaa649","article-title":"Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial","volume":"41","author":"Szarek","year":"2020","journal-title":"Eur Heart J"},{"key":"2024080903361746800_zwae110-B8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCULATIONAHA.123.066398","article-title":"Relating lipoprotein(a) concentrations to cardiovascular event risk after acute coronary syndrome: a comparison of 3 tests","volume":"149","author":"Szarek","year":"2024","journal-title":"Circulation"},{"key":"2024080903361746800_zwae110-B9","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"2024080903361746800_zwae110-B10","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwae110\/57184261\/zwae110.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/31\/10\/e75\/58778496\/zwae110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/31\/10\/e75\/58778496\/zwae110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T03:37:07Z","timestamp":1723174627000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/31\/10\/e75\/7631469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,3,19]]},"published-print":{"date-parts":[[2024,8,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwae110","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,3,19]]}}}